These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 21401612)
1. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. Ma T; Huang C; Zong G; Zha D; Meng X; Li J; Tang W J Pharm Pharmacol; 2011 Apr; 63(4):587-93. PubMed ID: 21401612 [TBL] [Abstract][Full Text] [Related]
2. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of compound glycyrrhizin liposome on fibrosis of the rats with nonalcoholic steatohepatitis]. Ye HJ; Wei SL; Wang HC; Liu XY; Wan HJ; Yi XR; Yuan YC; Kong XP Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):877-8. PubMed ID: 19958654 [No Abstract] [Full Text] [Related]
4. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452 [TBL] [Abstract][Full Text] [Related]
5. Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. Yang HY; Tzeng YH; Chai CY; Hsieh AT; Chen JR; Chang LS; Yang SS Nutrition; 2011 Sep; 27(9):943-8. PubMed ID: 21333494 [TBL] [Abstract][Full Text] [Related]
6. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet. Wang JQ; Li J; Zou YH; Cheng WM; Lu C; Zhang L; Ge JF; Huang C; Jin Y; Lv XW; Hu CM; Liu LP J Ethnopharmacol; 2009 Jan; 121(1):54-60. PubMed ID: 18977425 [TBL] [Abstract][Full Text] [Related]
7. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease. Duan XY; Zhao HP; Fan JG J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835 [TBL] [Abstract][Full Text] [Related]
8. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. Hong XZ; Li LD; Wu LM Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732 [TBL] [Abstract][Full Text] [Related]
9. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Staels B; Rubenstrunk A; Noel B; Rigou G; Delataille P; Millatt LJ; Baron M; Lucas A; Tailleux A; Hum DW; Ratziu V; Cariou B; Hanf R Hepatology; 2013 Dec; 58(6):1941-52. PubMed ID: 23703580 [TBL] [Abstract][Full Text] [Related]
10. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Zou Y; Li J; Lu C; Wang J; Ge J; Huang Y; Zhang L; Wang Y Life Sci; 2006 Aug; 79(11):1100-7. PubMed ID: 16624332 [TBL] [Abstract][Full Text] [Related]
11. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis. IbaƱez P; Solis N; Pizarro M; Aguayo G; Duarte I; Miquel JF; Accatino L; Arrese M J Gastroenterol Hepatol; 2007 Jun; 22(6):846-51. PubMed ID: 17565640 [TBL] [Abstract][Full Text] [Related]
12. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats]. Zheng LY; Pan JQ; Lv JH Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. Hong X; Tang H; Wu L; Li L J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice. Liu Q; Shen WF; Sun HY; Fan DF; Nakao A; Cai JM; Yan G; Zhou WP; Shen RX; Yang JM; Sun XJ Liver Int; 2010 Aug; 30(7):958-68. PubMed ID: 20492513 [TBL] [Abstract][Full Text] [Related]
15. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats. Murayama H; Ikemoto M; Nagata A J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438 [TBL] [Abstract][Full Text] [Related]
16. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. Pan M; Song YL; Xu JM; Gan HZ J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545 [TBL] [Abstract][Full Text] [Related]
17. Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Takayama F; Nakamoto K; Totani N; Yamanushi T; Kabuto H; Kaneyuki T; Mankura M J Oleo Sci; 2010; 59(8):407-14. PubMed ID: 20625232 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878 [TBL] [Abstract][Full Text] [Related]
19. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [TBL] [Abstract][Full Text] [Related]
20. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease]. Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]